Cargando…
PReS-FINAL-2110: Tocilizumab for patients with oligoarticular juvenile idiopathic arthritis refractory to conventional therapy
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044449/ http://dx.doi.org/10.1186/1546-0096-11-S2-P122 |
| _version_ | 1782319147100667904 |
|---|---|
| author | Sato, T Nishimura, K Nozawa, T Kanetaka, T Kikuchi, M Hara, R Sakurai, N Yamazaki, K Takeuchi, Y Yokota, S |
| author_facet | Sato, T Nishimura, K Nozawa, T Kanetaka, T Kikuchi, M Hara, R Sakurai, N Yamazaki, K Takeuchi, Y Yokota, S |
| author_sort | Sato, T |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4044449 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40444492014-06-19 PReS-FINAL-2110: Tocilizumab for patients with oligoarticular juvenile idiopathic arthritis refractory to conventional therapy Sato, T Nishimura, K Nozawa, T Kanetaka, T Kikuchi, M Hara, R Sakurai, N Yamazaki, K Takeuchi, Y Yokota, S Pediatr Rheumatol Online J Poster Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4044449/ http://dx.doi.org/10.1186/1546-0096-11-S2-P122 Text en Copyright © 2013 Sato et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Sato, T Nishimura, K Nozawa, T Kanetaka, T Kikuchi, M Hara, R Sakurai, N Yamazaki, K Takeuchi, Y Yokota, S PReS-FINAL-2110: Tocilizumab for patients with oligoarticular juvenile idiopathic arthritis refractory to conventional therapy |
| title | PReS-FINAL-2110: Tocilizumab for patients with oligoarticular juvenile idiopathic arthritis refractory to conventional therapy |
| title_full | PReS-FINAL-2110: Tocilizumab for patients with oligoarticular juvenile idiopathic arthritis refractory to conventional therapy |
| title_fullStr | PReS-FINAL-2110: Tocilizumab for patients with oligoarticular juvenile idiopathic arthritis refractory to conventional therapy |
| title_full_unstemmed | PReS-FINAL-2110: Tocilizumab for patients with oligoarticular juvenile idiopathic arthritis refractory to conventional therapy |
| title_short | PReS-FINAL-2110: Tocilizumab for patients with oligoarticular juvenile idiopathic arthritis refractory to conventional therapy |
| title_sort | pres-final-2110: tocilizumab for patients with oligoarticular juvenile idiopathic arthritis refractory to conventional therapy |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044449/ http://dx.doi.org/10.1186/1546-0096-11-S2-P122 |
| work_keys_str_mv | AT satot presfinal2110tocilizumabforpatientswitholigoarticularjuvenileidiopathicarthritisrefractorytoconventionaltherapy AT nishimurak presfinal2110tocilizumabforpatientswitholigoarticularjuvenileidiopathicarthritisrefractorytoconventionaltherapy AT nozawat presfinal2110tocilizumabforpatientswitholigoarticularjuvenileidiopathicarthritisrefractorytoconventionaltherapy AT kanetakat presfinal2110tocilizumabforpatientswitholigoarticularjuvenileidiopathicarthritisrefractorytoconventionaltherapy AT kikuchim presfinal2110tocilizumabforpatientswitholigoarticularjuvenileidiopathicarthritisrefractorytoconventionaltherapy AT harar presfinal2110tocilizumabforpatientswitholigoarticularjuvenileidiopathicarthritisrefractorytoconventionaltherapy AT sakurain presfinal2110tocilizumabforpatientswitholigoarticularjuvenileidiopathicarthritisrefractorytoconventionaltherapy AT yamazakik presfinal2110tocilizumabforpatientswitholigoarticularjuvenileidiopathicarthritisrefractorytoconventionaltherapy AT takeuchiy presfinal2110tocilizumabforpatientswitholigoarticularjuvenileidiopathicarthritisrefractorytoconventionaltherapy AT yokotas presfinal2110tocilizumabforpatientswitholigoarticularjuvenileidiopathicarthritisrefractorytoconventionaltherapy |